B Braun Aesculap is a division of the B. Braun Group and one of the most respected manufacturers of surgical instruments, sutures, and sterilization container systems. In 2025, B. Braun Kenya has started offering the Aesculap portfolio. Our specialists have started reaching out to all major institutions offering solutions to Theatres, Central Sterile Supply Departments and Cathlabs across the country.
Sustainable supplies, economic solutions, best quality and extended services (e.g. repair of surgical instruments) are the pillars on which we build our partnership with all surgical institutions in Kenya.
Sutures: a comprehensive portfolio of absorbable and non-absorbable sutures
Biosurgicals: Hernia meshes and Histoacryl ®
Instrument Sets: for general and specialized surgery
Drills: Power Tools for orthopedic, traumatology, neuro, cranial/spine
Skin grafting Dermatomes: for burn reconstruction or covering large wounds
Containers, Baskets and Trays: for sterile goods management
Coronary Angioplasty: Stents and Balloons for interventional Cardiology (portfolio has been in Kenya since 2023)
In January 2023 Braun Kenya has started selling their AESCULAP Coronary Vascular Products in Kenya. This portfolio, that had previously been marketed by a local distributor, includes: Drug-coated Balloons (DCB), Sequent Please Neo, PTCA Balloons (POBA) Sequent Neo, Sequent Neo NC, Drug-eluting Stents, Coroflex Isar Neo,
Having supplied Rwanda with an essential component for their Pfizer vaccination program in 2021, B. Braun Kenya won a contract to supply over one million units of Infusion Solutions to Rwanda in the same year. In 2022 Braun Kenya will provide a multiple of this volume to Rwanda.
By the end of 2021 we commenced the production of Eye Drops in our factory in EPZA Athi River. The Eye drops are produced with state-of the-art machines according to the highest quality standards. First products have been delivered to South Sudan and Tanzania.
On July 18, B. Braun Kenya celebrated a milestone that the company had achieved in their production plant for Infusion Solutions and EyeEar Drops within the Export Processing Zone (EPZ) in Athi River in the greater Nairobi area.
The celebration marked the production of the 10th million infusion solution at the state-of-the-art facility that has been operational since 2021. This achievement highlights B. Braun’s commitment to enhancing healthcare access and quality across East Africa by producing essential medical supplies locally.
The production plant in Athi River is equipped with cutting-edge technology and adheres to international quality standards, ensuring that the infusion solutions and eye/ear drops manufactured meet the highest quality criteria. The facility has created employment opportunities for local talent while facilitating knowledge transfer and skill development in pharmaceutical manufacturing.
Strategic Importance
The milestone is particularly significant as it demonstrates B. Braun’s successful implementation of its localization strategy in Africa. By establishing production capabilities within Kenya, the company has enhanced supply chain resilience, reduced dependence on imports, and contributed to the country’s economic development through job creation and technology transfer.
During the celebration, company officials emphasized the importance of this achievement in B. Braun’s broader mission of improving healthcare accessibility across Africa. The locally produced infusion solutions have already been supplied to healthcare facilities in Kenya and neighboring countries, including South Sudan and Tanzania.
“This milestone represents our commitment to advancing healthcare in East Africa through local production of high-quality medical supplies. Our state-of-the-art facility in Athi River enables us to respond more effectively to the region’s healthcare needs while contributing to Kenya’s manufacturing sector.”
Future Plans
Building on this success, B. Braun Kenya has announced plans to expand its production capabilities and product portfolio. The company aims to increase its manufacturing capacity to meet growing demand across East Africa and potentially extend its reach to other parts of the continent.
The expansion plans include potential diversification of the product range to include additional medical solutions that are in high demand in the region. This strategic growth initiative aligns with B. Braun’s global vision of enhancing healthcare systems through innovation and localized solutions.
10 Million
Infusion solutions produced
Since 2021
Production facility operational
East Africa
Regional supply network
The celebration event was attended by company officials, government representatives, healthcare partners, and employees who have contributed to this significant achievement. It underscored B. Braun’s commitment to its long-term presence in Kenya and its dedication to enhancing healthcare infrastructure across the region.
